Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.33B | 2.32B | 2.38B | 2.42B | 1.79B |
Gross Profit | 1.10B | 1.10B | 1.14B | 1.18B | 804.47M |
EBITDA | 66.72M | 35.84M | 136.66M | 190.36M | -59.66M |
Net Income | -18.89M | -16.83M | 71.92M | 114.85M | -56.03M |
Balance Sheet | |||||
Total Assets | 1.34B | 1.33B | 1.46B | 1.56B | 1.59B |
Cash, Cash Equivalents and Short-Term Investments | 34.01M | 35.16M | 47.99M | 320.52M | 215.09M |
Total Debt | 485.09M | 522.94M | 580.43M | 632.64M | 734.04M |
Total Liabilities | 788.57M | 758.69M | 849.46M | 959.63M | 1.02B |
Stockholders Equity | 546.97M | 571.20M | 606.97M | 602.47M | 566.76M |
Cash Flow | |||||
Free Cash Flow | 46.75M | 34.49M | -224.82M | 185.97M | 133.61M |
Operating Cash Flow | 87.89M | 94.80M | -164.88M | 239.87M | 157.74M |
Investing Cash Flow | -41.13M | -60.00M | -59.93M | -33.90M | -24.02M |
Financing Cash Flow | -47.00M | -47.58M | -45.53M | -101.17M | -3.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $211.67M | 6.17 | 41.77% | 2.14% | -2.24% | -33.43% | |
57 Neutral | $248.49M | ― | -29.52% | ― | 1.85% | -337.77% | |
56 Neutral | HK$24.19B | 4.02 | -1.57% | 11.14% | 0.06% | -64.76% | |
54 Neutral | $112.78M | ― | -9.20% | 8.66% | -4.22% | -386.70% | |
48 Neutral | $226.40M | 1,158.18 | 0.23% | ― | 3.01% | ― | |
40 Underperform | $221.72M | ― | -3.07% | ― | 1.85% | 22.34% | |
40 Underperform | $92.66M | ― | -521.67% | ― | -12.15% | 75.86% |
On February 6, 2025, Genesco Inc.’s Compensation Committee approved amendments to its Employment Protection Agreement. The changes allow Termination Notices during active negotiations for transactions that could lead to a Change in Control and remove automatic termination upon reaching a certain retirement age, impacting executive employment stability during potential company transitions.